Macro Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-12-2024
- Paid Up Capital ₹ 0.35 M
as on 22-12-2024
- Company Age 11 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.11 M
as on 22-12-2024
- Revenue 43.58%
(FY 2020)
- Profit 4.61%
(FY 2020)
- Ebitda 44.17%
(FY 2020)
- Net Worth 30.03%
(FY 2020)
- Total Assets 30.01%
(FY 2020)
About Macro Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M.
The company currently has active open charges totaling ₹7.11 M.
Ranjna, Arun Wayyar, and Bharat Bhushan serve as directors at the Company.
- CIN/LLPIN
U24232CH2013PTC034871
- Company No.
034871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Macro Labs Private Limited offer?
Macro Labs Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, PCD Pharma Franchise, Sexual Wellness Products, Fertility Enhancer, Digestive System Drugs & Medicines, Laxatives, Gastrointestinal Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Brain & Nervous System Drugs.
Who are the key members and board of directors at Macro Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjna  | Director | 12-Dec-2013 | Current |
| Arun Wayyar | Director | 12-Dec-2013 | Current |
| Bharat Bhushan | Director | 12-Dec-2013 | Current |
Financial Performance of Macro Labs.
Macro Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 43.58% increase. The company also saw a slight improvement in profitability, with a 4.61% increase in profit. The company's net worth Soared by an impressive increase of 30.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macro Labs?
In 2020, Macro Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Feb 2021 | ₹4.71 M | Open |
State Bank Of India Creation Date: 30 Jul 2014 | ₹2.40 M | Open |
How Many Employees Work at Macro Labs?
Unlock and access historical data on people associated with Macro Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macro Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macro Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
